Cami Denning
Nurse Practitioner · Scottsdale, AZNPI 1144093196
Payments from drug & device makers
Across 217 payments — averaging $17.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- TG Therapeutics, Inc.$301
- Eisai Inc.$251
- Pfizer$182
- Argenx US, Inc.$134
- Biogen$97
- plus $900 from 21 others
What the payments were for
- Food & beverage$3,895100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 137 | $2,029 |
| TG Therapeutics, Inc. | 10 | $301 |
| Eisai Inc. | 6 | $251 |
| Pfizer | 9 | $182 |
| Argenx US, Inc. | 6 | $134 |
| Biogen | 6 | $97 |
| Genentech USA, Inc. | 3 | $88 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| AstraZeneca | 4 | $82 |
| Teva Pharmaceuticals USA, Inc. | 3 | $77 |
| UCB, Inc. | 4 | $72 |
| Lilly USA, LLC | 3 | $54 |
| Tonix Medicines, Inc. | 3 | $53 |
| Neurelis, Inc. | 3 | $50 |
| Amgen | 2 | $49 |
| Merz Pharmaceuticals, LLC | 2 | $48 |
| Cycle Pharmaceuticals Inc | 2 | $48 |
| Amneal Pharmaceuticals LLC | 2 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $29 |
| Neurocrine Biosciences, Inc. | 1 | $23 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Novartis | 1 | $17 |
| SK Life Science, Inc. | 1 | $17 |
| Springworks Therapeutics, Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| Lundbeck LLC | 1 | $14 |
| Aucta Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,895 in reported general payments places this provider in the 90th percentile of 1,719 nurse practitioner providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Donepezil Hcl | 58 | $877 |
| Levetiracetam | 16 | $784 |
| Memantine Hcl | 16 | $407 |
| Duloxetine Hcl | 22 | $366 |
| Gabapentin | 31 | $275 |
| RizatriptanRizatriptan Benzoate | 11 | $212 |
| Primidone | 13 | $95 |
| Amitriptyline Hcl | 13 | $67 |
| Alprazolam | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Scottsdale
- Kristen HerzogScottsdale$162K
- Kelley RoneScottsdale$29K
- Jill StudyScottsdale$24K
- Jennifer BarbosaScottsdale$21K
- Jessica LoweryScottsdale$16K
- Ronald OrdasScottsdale$8K
- Theresa LongoScottsdale$8K
- Samantha DeberryScottsdale$8K
- Meagan GruwellScottsdale$7K
- Ann MooreGlendale$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.